The fibril zipper

Credit: COURTESY OF MICHAEL SAWAYA, DAVID EISENBERG/UCLA" /> Credit: COURTESY OF MICHAEL SAWAYA, DAVID EISENBERG/UCLA The paper: R. Nelson et al., "Structure of the cross-β spine of amyloid-like fibrils," Nature, 435:773-8, 2005. (Cited in 119 papers) The finding: In 2005, Howard Hughes Medical Institute Investigator David Eisenberg and his team at the University of California Los Angeles successfully determined the atomic structure o

Written byAndrea Gawrylewski
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

The paper:

R. Nelson et al., "Structure of the cross-β spine of amyloid-like fibrils," Nature, 435:773-8, 2005. (Cited in 119 papers)

The finding:

In 2005, Howard Hughes Medical Institute Investigator David Eisenberg and his team at the University of California Los Angeles successfully determined the atomic structure of the protein fibrils formed from sub-pieces of the yeast protein Sup35.

The jargon:

The team was able to image the protein fibril structures from pieces of the protein only seven and then six amino acids in length, each showing their long side chains bound together like Velcro. Eisenberg's team termed this effect the "Dry Steric Zipper," referring to the fact that the structure forms by dehydrating the region between the protein sheets to form an interlocking zone.

The follow up:

In subsequent research, using the original six-amino-acid structure as a template, they have been able to find human sequences likely to form ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies